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and exhibits more dispersed values. Moreover, the latter in-
dex is no longer representative of mU osm in patients with 
CKD as it declines much more quickly with declining glomer-
ular filtration rate than mU osm .  Conclusion: The eU osm is a 
valid marker of urine concentration in population-based and 
CKD cohorts. The UCI can provide an estimate of urine con-
centration when no other measurement is available, but 
should be used only in subjects with normal renal function. 
 © 2017 S. Karger AG, Basel 
 Introduction 
 The interest in the influence of the antidiuretic hor-
mone or vasopressin (AVP) as a significant player in vari-
ous kidney, cardiovascular, and metabolic diseases has 
been revived recently  [1–4] . The availability of non-pep-
tide, orally active selective AVP receptor antagonists (vap-
tans)  [5, 6] and of a reliable ELISA for the measurement of 
copeptin, a validated surrogate of AVP  [7, 8] , has opened 
the door for a number of studies addressing the AVP/thirst 
pathway and osmoregulation in general (see review in  [9] ).
 Independent of the well-known contribution of antid-
iuretic hormone to various forms of water disorders, re-
cent epidemiological studies have shown significant as-
sociations between indices of the AVP/hydration system 
 Keywords 
 Sodium · Potassium · Urea · Circadian rhythm · Water 
balance · Chronic kidney disease 
 Abstract 
 Background: The importance of vasopressin and/or urine 
concentration in various kidney, cardiovascular, and meta-
bolic diseases has been emphasized recently. Due to techni-
cal constraints, urine osmolality (U osm ), a direct reflect of uri-
nary concentrating activity, is rarely measured in epidemio-
logic studies.  Methods: We analyzed 2 possible surrogates of 
U osm in 4 large population-based cohorts (total  n = 4,247) 
and in patients with chronic kidney disease (CKD,  n = 146). 
An estimated U osm (eU osm ) based on the concentrations of 
sodium, potassium, and urea, and a urine concentrating in-
dex (UCI) based on the ratio of creatinine concentrations in 
urine and plasma were compared to the measured U osm 
(mU osm ).  Results: eU osm is an excellent surrogate of mU osm , 
with a highly significant linear relationship and values within 
5% of mU osm ( r = 0.99 or 0.98 in each population cohort). 
Bland-Altman plots show a good agreement between eU osm 
and mU osm with mean differences between the 2 variables 
within ±24 mmol/L. This was verified in men and women, in 
day and night urine samples, and in CKD patients. The rela-
tionship of UCI with mU osm is also significant but is not linear 
 Received: February 13, 2017 
 Accepted: April 12, 2017 
 Published online: June 7, 2017 
NephrologyAmerican    Journal of
 Lise Bankir 
 INSERM UMRS, Centre de Recherche des 
Cordeliers,  1138, 15 rue de l’Ecole de Médecine 
 FR–75006 Paris (France) 
 E-Mail lise.bankir   @   inserm.fr 
 © 2017 S. Karger AG, Basel
 
 www.karger.com/ajn 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.2
03
.4
6 
- 2
/8
/2
01
8 
4:
05
:5
8 
PM
 Surrogates of U osm Am J Nephrol 2017;46:26–36
DOI: 10.1159/000475769
27
and the incidence or progression of diseases including 
chronic kidney disease (CKD), autosomal dominant 
polycystic kidney disease, diabetic nephropathy, obesity, 
metabolic syndrome, and insulin resistance  [4, 10–21] . A 
number of experimental studies have demonstrated the 
adverse effects of AVP or a low level of hydration in ani-
mal models of these disorders  [10, 22–26] . A recent dou-
ble-blind, placebo-controlled clinical trial, using a selec-
tive AVP V2 receptor antagonist, tolvaptan, proved to 
bring significant benefit over a 3-year period in patients 
with autosomal dominant polycystic kidney disease and 
well preserved renal function  [27] .
 Because AVP is difficult to measure due to its small 
mass, very low circulating concentrations, poor stability 
in vitro, and time-consuming assay, most of the recent 
studies dealing with this hormone rely on the measure-
ment of copeptin (a peptide that is part of the pre-prohor-
mone containing AVP) in plasma or, more indirectly, on 
fluid intake or daily urine volume  [28, 29] . Urine osmo-
larity (U osm ), the most direct parameter reflecting the ac-
tion of AVP on distal tubular segments of the kidney, is 
rarely measured due to technical constraints, and is thus 
usually not available in epidemiologic studies.
 Various surrogates of U osm have been used in clinical 
studies. They include the specific urine density (UD) or 
the refraction index that give only an approximate value 
of the solute content in the urine and are subjected to sev-
eral biases including distortion in the case of proteinuria 
and poor precision of readings. Two other surrogates are 
the urine concentrating index (UCI) based on the han-
dling of creatinine by the kidney  [30, 31] , and the  estimated 
U osm (eU osm ) based on the concentration of the 3 main 
osmoles present in the urine: sodium, potassium, and 
urea  [31, 32] . To our knowledge, the validity of these 
2 surrogates has not been evaluated in large, population-
based cohorts with normal or altered renal function. The 
aim of the present study was to assess the value of eU osm 
and UCI compared to measured U osm (mU osm ) in large 
population-based and CKD cohorts, and to test the influ-
ence of sample type, gender, and age on these markers.
 Subjects and Methods 
 Cohorts 
 The general characteristics of the subjects belonging to the dif-
ferent cohorts are presented in  Table 1 .
 Generation Scotland:Scottish Family Health Study (GS:SFHS) 
and Croatia-Korcula 
 Aberdeen and Glasgow subjects were selected from the Gen-
eration Scotland study, a family-based genetic epidemiology study 
that included 24,000 volunteers from across Scotland, as previ-
ously described  [33] . Biological samples including morning spot 
urine were collected during participation from 2006 to 2011  [34] . 
We also studied subjects from the Croatia-Korcula cohort, a fam-
ily-based, cross-sectional study from the island of Korcula  (Croatia) 
that initially included 965 subjects, as previously described  [35] . 
Studies of these 3 cohorts included clinical information, biochem-
ical measurements, and lifestyle and health questionnaires. For the 
present study, subjects from these 3 cohorts were randomly se-
lected for measurement of U osm ( n  = 554 from GS:SFHS Aberdeen, 
2,305 from GS:SFHS Glasgow and 463 from Croatia-Korcula). All 
participants provided written informed consent. For GS:SFHS, na-
tional ethical approval has been obtained from the National Health 
Service Tayside Research Ethics committee. The Croatia-Korcula 
study was approved by the Ethical Committee of the Medical 
School, University of Zagreb.
Table 1.  Demographic information about the different cohorts
Cohort Croatia-Korcula GS:SFHS
Aberdeen
GS:SFHS
Glasgow
SKIPOGH
day
SKIPOGH 
night
CKD Necker
Number 463 554 2,305 925 Idem 146
Sample type Spot Spot Spot Day period Night period 24 h
Age, years 58 (19–87) 57 (19–88) 53 (18–93) 47 (18–90) Idem 64 (17–86)
Gender: M/W, % 41/59 43/57 41/59 47/53 Idem 59/41
BMI, kg/m2 27.97±0.21 27.22±0.22 26.97±0.21 25.03±0.15 Idem 24.16±0.30
mUosm, mosm/kg H2O 668±10 524±10 540±5 457 (110–1,174) 541 (67–1,304) 396±13
eUosm, mosm/L 664±9 526±11 547±5 450 (118–1,142) 513 (61–1,223) 381±12
UCI 165±4 119±3 117±2 114±2 145±3 41.6±3.6
Uurea, mmol/L 285±5 225±5 250±3 227±4 296±5 177±6
UNa, mmol/L 113.8±2.2 79.3±2.0 83.9±1.0 94.8±1.6 93.4±1.6 68.7±2.8
UK, mmol/L 65.9±1.6 63.5±1.5 64.9±0.8 47.4±0.8 32.7±0.6 33.3±1.3
eGFR, mL/min/1.73 m2 83.4±1.1 92.2±0.7 89.1±0.4 96.3±0.6 – 46.2±2.5
Means + SEM or median (interval).
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 Swiss Kidney Project on Genes in Hypertension 
 Swiss Kidney Project on Genes in Hypertension (SKIPOGH) is 
a family- and population-based cross-sectional multicenter study 
that examines the genetic determinants of blood pressure. Partici-
pants were recruited in 2009–2013 in the cantons of Bern and 
 Geneva, and the city of Lausanne. Detailed methods have been 
previously described  [36, 37] . The study visit was performed in the 
morning after an overnight fast. Participants were asked to bring 
urine of the previous 24 h collected separately during day and night 
periods defined according to each participant’s self-reported bed-
time and wake-up time. The SKIPOGH study was approved by the 
Human Research Ethics Committee of Lausanne University Hos-
pital and University of Lausanne (Lausanne, Switzerland), Ethics 
Committee for the Research on Human Beings of Geneva Univer-
sity Hospitals (Geneva, Switzerland), and Ethics Committee of the 
Canton of Bern (Bern, Switzerland).
 CKD Patients 
 This study includes 146 outpatients with CKD of diverse eti-
ologies and various levels of renal dysfunction, who were attending 
the Nephrology Department of Necker Hospital (Paris, France) in 
1993 for a bi-annual checkup  [19, 38] . All patients provided 24-h 
urine. Informed consent was obtained for storage of the samples 
and additional future measurements to enable a more complete 
understanding of the pathophysiological characteristics related to 
CKD. On the freshly collected plasma and urine samples, osmolal-
ity was measured with a freezing point osmometer (Roebling, 
 Berlin, Germany). Creatinine concentration was measured by the 
Jaffe colorimetric method and creatinine clearance in mL/1.73 m 2 
was used as an estimate of glomerular filtration rate (GFR). Con-
centration of urinary solutes was measured with a classical auto-
matic multianalyzer.
 Measurements in Plasma and Urine Samples 
 In the 4 population-based cohorts, urine samples were kept fro-
zen at –80   °   C until U osm and urinary solute concentrations were 
measured. Sodium, potassium, glucose, creatinine, and urea were 
measured with a Beckman Coulter Synchron System Assays (Uni-
cell DxC Synchron Clinical System). The CKD-EPI formula was 
used to calculate eGFR  [39] . U osm was measured on 20 μL samples 
by the freezing point depression technique using an Advanced Os-
mometer (Norwood, MA, USA). A control (Clinitrol 290) and a set 
of calibration standards (50, 850, and 2,000 mosm/kg H 2 O) were 
used before running each batch. The intra-assay coefficient of vari-
ability was 0.19% and the inter-assay coefficient of variability was 
1.32%.
 Calculations and Statistical Analyses 
 Most modern osmometers measure the osmolality of the fluids in 
milliosmoles per kilogram of water (mosm/kg H 2 O) 1 . Osmolarity 
expresses the concentration of osmotically active molecules in mil-
liosmoles per liter of water (mosm/L). Sweeney and Beuchat  [40] 
described the technical aspects and limitations of osmometry meth-
ods and provided detailed considerations about the concepts of os-
motic pressure, osmolarity, osmolality, and solute concentrations.
 Estimated U osm 
 The major urinary solutes, accounting for more than 90% of all 
urinary osmoles, are urea and the 2 cations sodium and potassium 
along with their accompanying anions. Thus, their cumulated con-
centrations (in mmol/L) should be close to the actual U osm (in 
mosm/L). An eU osm can be calculated according to the following 
formula:
 eU osm  = (U Na + U K ) * 2 + U urea 
 where U Na , U K , and U urea are the urinary concentrations of sodium, 
potassium, and urea, respectively, in mmol/L. U Na + U K is multi-
plied by 2 to account for the accompanying anions. If urea was 
measured as urea nitrogen, it should be remembered that there are 
2 atoms of nitrogen (MW  = 14) per molecule of urea. Urea in 
mmol/L = urea nitrogen in mg/dL × 0.357 (explanation: urea ni-
trogen in mg/dL multiplied by 10 [conversion of dL to L] and di-
vided by 14 × 2 [mg N per mmol urea]). In case of significant gly-
cosuria, glucose concentration can be added to the formula. 
 Urine Concentrating Index 
 Creatinine is freely filtered and is assumed to undergo negli-
gible secretion or reabsorption along the nephron when kidney 
function is normal. Thus, the concentration of creatinine in urine 
relative to that in plasma (U creat and P creat , respectively), that is, the 
ratio of urine-to-plasma creatinine concentrations, is proportion-
al to the fraction of filtered water that has been reabsorbed to con-
centrate the solutes in the urine. This ratio provides an UCI, a ratio 
that has no unit: 
 UCI = U creat /P creat 
 Statistical Analyses 
 The Statistical Package for Social Sciences (SPSS) version 19 
(IBM Corporation, New York) and GraphPad Prism 5 were used 
to carry out the statistical analyses and generate the figures. Results 
are shown as means ± SEM for normally distributed variables, or 
as medians and 25–75% interquartile range (IQR) for other vari-
ables. The agreement between mU osm and eU osm was assessed by 
 Bland-Altman plots. The Shapiro-Wilk test was used to assess the 
distribution of mU osm in the SKIPOGH study. Correlations were 
studied using Pearson’s correlation analysis (in case of normality) 
or Spearman’s rho test (for other variables). Wilcoxon signed-rank 
test was used to compare repeated measures for day and night 
urine samples of the SKIPOGH subjects. The significance level was 
set at 5%.
 Results 
 U osm Surrogates in Population-Based Cohorts 
 Large variations in urine concentration are observed 
among individuals. The mU osm in different subjects var-
ies from  ≈ 150 to 1,200 mosm/kg H 2 O in spot urine of the 
 1    The terms osmolarity or osmolality should be preferred to “osmotic pres-
sure” because this physical osmotic force is not a pressure. It was named in 
this way in the past, when osmolarity was evaluated indirectly as a hydrostat-
ic pressure generated by an unknown fluid opposed to a reference fluid, sepa-
rated by a semi-permeable membrane. The measurements were expressed 
in mm height between the levels of the 2 fluids in the 2 compartments. 
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3 population-based cohorts, as well as in day and night 
urine of the SKIPOGH cohort ( Fig. 1 a,  2 b). A substantial 
number of subjects (21%) dilute their urine below plasma 
osmolality whereas others (9%) concentrate their urine 
up to 3 times more than the level of plasma osmolality 
( Fig. 2 a). These extreme mU osm are not associated with 
differences in eGFR.
 Highly significant linear correlations are observed 
between mU osm and eU osm in all populations (Croatia- 
Korcula  r   = 0.98, GS:SFHS Aberdeen  r   = 0.98, 
GS:SFHS Glasgow  r  = 0.99;  Fig. 1 a,  2 b). The best-fit lin-
ear regression lines are almost superimposed with the 
medians. Bland-Altman plots show a good agreement 
between eU osm and mU osm in the 3 population-based 
cohorts (online suppl. Table 1; for all online suppl. ma-
terial, see www.karger.com/doi/10.1159/000475769). 
This is reflected in the small bias values (Croatia-Kor-
cula bias = 24, GS:SFHS Aberdeen bias = –6, GS:SFHS 
Glasgow bias  = –23), and relatively narrow precision 
range (Croatia-Korcula  = –44  to 90, GS:SFHS Aber-
deen = –54 to 43, GS:SFHS Glasgow = –80 to 34). Plot 
for the GS:SFHS Aberdeen population is given as an ex-
ample in  Figure 3 .
 Although the relations between UCI and mU osm are 
significant, they exhibit a relatively large dispersion of 
individual values, increasing with increasing osmolality 
( Fig.  1 b,  2 c). Nonetheless, as an average, the ratio of 
UCI  to mU osm is fairly constant (0.20, 0.21, and 0.22 
for mU osm  = 300, 600, and 900 mosm/kg H 2 O, respec-
tively). 
 The possible influence of glycosuria that occurred in 
some subjects on eU osm was evaluated. Among 3,322 
 Fig. 1. Comparison of urine osmolality surrogates with measured 
urine osmolality.  a Linear correlation between measured osmo-
lality and estimated osmolarity in 3 cohorts. Croatia-Korcula: 
mU osm  = 1.03 eU osm + 3.3 ( p  < 0.001,  r  = 0.98); GS:SFHS Aber-
deen: mU osm   = 0.99 eU osm – 4.4 ( p   < 0.001,  r   = 0.98); 
GS:SFHS Glasgow: mU osm  = 0.96 eU osm + 11 ( p  < 0.001,  r  = 0.99). 
The thin vertical lines show mU osm of 300 and 900 mosm/kg H 2 O, 
that is, approximatively 1 time and 3 times the plasma osmolal-
ity.  b Quadratic correlation between UCI and measured urine 
osmolality in 3 cohorts. Croatia-Korcula: mU osm  = 5.04 UCI – 
0.009 UCI 2 + 126 ( p   < 0.001,  r   = 0.76); GS:SFHS Aberdeen: 
mU osm  = 5.52 UCI – 0.009 UCI 2 + 28 ( p  < 0.001,  r  = 0.90); GS:SFHS 
Glasgow: mU osm  = 4.89 UCI – 0.006 UCI 2 + 90 ( p  < 0.001,  r  = 
0.89). Black lines represent the best-fit curves. Red thin lines rep-
resent the 95% CIs. Dotted lines in the top panel represent the 
medians. 
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subjects of the 3 cohorts in which urinary glucose was 
available, 58 exhibited glycosuria >1.66 mmol/L  [41] 
(mean ± SEM 11.58 ± 2.28 mmol/L; range 1.7–86.8). 
Their age and eGFR were 57.0 ± 1.8 years and 86.8 ± 2.4 
mL/min/1.73 m 2 , respectively. mU osm in these subjects 
was 642 ± 32 mosm/kg H 2 O. eU osm , calculated without 
or with the addition of urinary glucose, was 624 ± 31 
and 635 ± 32 mosm/L, respectively, both within 3% of 
mU osm .
 Urine osmolality (U osm ) is known to be higher in 
men than in women. This was verified in the cohorts of 
the present study (online suppl. Table 2); men exhibited 
higher mU osm and eU osm than women although the 
magnitude of this gender difference differed among the 
3 populations. eU osm was very close to mU osm in both 
genders and the men/women ratio of eU osm was very 
similar to that for mU osm . For UCI, there was a tenden-
cy for more inter-individual variation in women than in 
men as well as lower men/women ratios which tended 
to underestimate the gender difference (online suppl. 
Table 2).
 U osm Surrogates in Day and Night Urine 
 In healthy subjects, urine is usually more concentrated 
during the night than during the day. We investigated if 
the relationships between mU osm , eU osm , and UCI are 
comparable in day and night urine of the 925 subjects of 
the SKIPOGH study ( Fig. 2 a). The Shapiro-Wilk test in-
dicates that these variables diverge from a normal distri-
bution (shown by a thin curve). Mean mU osm ± SEM dur-
ing day and night was, respectively, 520 ± 4 and 572 ± 
7 mosm/kg H 2 O. Median (IQR) values were 457 (334–
 Fig. 2. Daytime and night-time urine in the SKIPOGH population 
( n   = 925).  a Distribution of mU osm among SKIPOGH subjects. 
Thin curves represent the normal distribution model.  b Linear 
correlation between measured and estimated U osm in daytime and 
night-time urine.  c Quadratic correlation between UCI and mU osm 
in daytime versus night-time urine. Black lines represent the best-
fit curves and red thin lines 95% CIs ( b ,  c ). Dotted lines represent 
the medians ( b ). 
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676) and 541 (356–777) mosm/kg H 2 O, respectively ( p  < 
0.001, Wilcoxon signed-rank test). The histograms of 
mU osm during day and night do not follow a normal dis-
tribution and there is a tendency for a bimodal distribu-
tion during the night.
 Measured and eU osm values exhibit highly significant 
linear correlations in both day and night urine ( Fig. 2 b), 
as also observed in the spot urine of the other cohorts. 
Bland-Altman plots show a good agreement between 
eU osm and mU osm in day and night urine, as reflected by 
the small bias values (day bias = 9, night bias = 24) and 
the precision range (day –71 to 89, night –66 to 114;  Fig. 3 ; 
online suppl. Table 1). The relations between UCI and 
mU osm are best described by quadratic correlations. Thin 
red lines show the 95% CIs as in the 3 cohorts shown in 
 Figure 1 . UCI vs. mU osm values were more widely dis-
persed than eU osm vs. mU osm values.
 U osm Surrogates in CKD Patients 
 Table  2 compares the values of eU osm and UCI to 
those of mU osm in CKD patients, according to their lev-
el of renal function. In all CKD classes, eU osm is very 
close to mU osm . Both variables decline in parallel with 
declining eGFR. Bland-Altman plot show a relatively 
good agreement between the 2 methods, as reflected by 
the small bias value (15) and the precision range (–37 to 
67;  Fig. 3 ; online suppl. Table 1). In contrast, UCI de-
clines much more dramatically than mU osm . These dif-
ferences are due mostly to the progressive rise in plas-
ma  creatinine concentration (from 91 ± 5 to 514 ± 
34 μmol/L in the 2 extreme classes, a 5.6-fold increase) 
while urine creatinine concentration declines only 
2-fold as a result of a lower total creatinine excretion 
and a moderately higher 24-h urine volume. In these 
patients, a spot urine sample was collected in the morn-
ing following the 24-h urine collection ( Table 2 ). mU osm 
in morning urine is 10–20% higher than mU osm in 24-h 
urine, a difference that seems independent of the level 
of renal function.
 Discussion 
 The urine concentrating activity of the human kid-
ney was rarely investigated, except in a few conditions 
such as urolithiasis and diabetes insipidus. Recent ex-
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perimental and epidemiological findings have renewed 
the interest in the components of the water balance and 
in the parameters reflecting this integrative function  [1, 
4, 9, 18, 22, 24, 28, 29, 32, 42, 43] . It is indeed quite dif-
ferent for the kidney to excrete a daily osmolar load of 
900 mosm in 1 L of urine at 900 mosm/L or in 3 L of 
urine at 300 mosm/L. Increased urine concentration 
(associated with increased solute-free water reabsorp-
tion) results in a lower fractional excretion of several 
solutes and in a significant hyperfiltration, that is, at 
least in part, mediated by AVP acting on renal V2 re-
ceptors. It has been proposed that this hyperfiltration is 
mediated by changes in the composition of the tubular 
fluid at the macula densa, resulting from AVP’s action 
on water, sodium, and urea transport in the collecting 
duct and the resulting recycling of urea in the medulla 
(see review in  [9] ). U osm , the most direct reflect of the 
urine concentrating activity, is rarely measured in large 
cohorts because of technical issues (see below). The 
present study, in a cross-sectional design, describes 2 
practical, easily accessible surrogates of U osm and as-
sesses their validity by comparing the results to the ac-
tually mU osm in large cohorts of the population and in 
a group of patients with CKD. We also checked the val-
ue of these surrogates in various sample types (spot or 
24-h, day and night), and according to gender and renal 
function.
 Our results show that the estimated U osm , based on so-
dium, potassium, and urea concentrations, is an excellent 
surrogate of the measured  U osm . In most cases, eU osm is 
within ±5% of mU osm . This is similarly true in men and 
women, as well as in urine collected during day or night, 
and in patients with impaired renal function at any level 
of glomerular filtration rate. One may wonder how eU osm 
and mU osm may be so close when the formula used for the 
calculation of eU osm neglects the minor solutes that 
should however represent more than 5% of all urinary 
solutes. This is partly explained by the fact that the units 
are not the same.  eU osm is expressed in mosm/L while 
mU osm is in mosm/kg H 2 O. Because 1 L of water with dis-
solved solutes weights more than 1 kg, the osmolality is 
lower than the osmolarity. The 2 measures differ only 
modestly for solutions within the biological range. For 
example, a solution containing 140 mmol/L NaCl and 500 
mmol/L urea has an osmolarity  of 780 mosm/L and an 
osmolality of 751 mosm/kg H 2 O (i.e. 3.7% lower). This 
difference partially compensates for the missing solutes 
and thus contributes to the almost equality of eU osm and 
mU osm . Another factor is that electrolytes are assumed to 
be totally dissociated in the eU osm formula. Although the 
dissociation is high in solutions within the physiological 
range, it is less than 100%, thus also contributing to mod-
estly overestimate eU osm .
 UCI is a less accurate reflection of mU osm than eU osm 
because creatinine is known to undergo some secretion 
as well as some reabsorption along the tubule. The net 
result of these opposite effects depends on the rate of 
urine flow  [44] . Our study shows that individual val-
ues are fairly dispersed and the correlations between the 
2 variables are not linear. However, when no other ap-
proach is available, UCI remains a possible surrogate of 
urine concentration, provided it is applied to subjects 
with normal renal function. As clearly demonstrated in 
the present study, UCI diverges markedly from mU osm in 
patients with CKD, limiting its use when renal function 
is impaired and probably also when abnormal handling 
of creatinine or excessive 24-h intake of creatine are sus-
pected.
Table 2.  Osmolality and its surrogates in 147 CKD patients according to the level of renal function
CKD stage n Creatinine 
excretion, 
mmol/day
Spot mUosm, 
mosm/kg 
H2O
mUosm, 
mosm/kg 
H2O
eUosm, 
mosm/L
eUosm/mUosm UCI, 
Ucreat/Pcreat
UCI*100/mUosm1
Stage 1 (>90) 13 13.4±1.0 738±61 650±48 608±43 0.94±0.01 146±17 22.1±1.6
Stage 2 (60–89) 29 13.2±0.7 517±32 479±34 458±34 0.95±0.01 59±5 12.3±0.4
Stage 3 (30–59) 54 11.5±0.5 450±14 371±14 358±14 0.97±0.01 34±2 9.2±0.3
Stage 4 (15–29) 32 9.4±0.5 376±13 321±13 311±12 0.98±0.01 17±1 5.2±0.3
Stage 5 (<15) 19 8.1±0.5 318±11 296±12 291±12 0.98±0.02 7±1 2.5±0.2
 Means ± SEM.
CKD stages are shown with the limits of eGFR in mL/min/1.73 m2.
Spot mUosm = mUosm of a morning spot urine sample. All other values concern 24-h urine collection.
1 For the ratio of UCI/mUosm, UCI was multiplied by 100 to make the reading easier.
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 A few alternative methods for quantifying urine con-
centration have been used. UD (or specific gravity) may 
be evaluated in 7 colored grades with commercially avail-
able dipsticks (Labtix 8SG and Multistix 8SG AMES/ 
Bayer Diagnostics) or evaluated by refractometry using a 
hand-held refractometer (Pen Urine S.G., Atago, Tokyo, 
Japan)  [45] . In the DESIR study (a cohort of the French 
population), UD was measured with dipsticks in fresh 
spot morning urine samples from 1,604 subjects, and 
eU osm was calculated (same formula as here)  [8] . Median 
(IQR) eU osm was 664 (272) mosm/L. UD was well corre-
lated with eU osm ( r  = 0.446,  p  < 0.00001). Another study 
showed that UD was well correlated with mU osm but the 
wide dispersion made it “impossible to use UD as a de-
pendable clinical estimate of U osm ”  [46] . Moreover, UD 
or specific gravity cannot be used if urine contains pro-
teins or glucose  [47] .
 It is important to note that U osm varies greatly among 
different subjects, as shown in the 4 populations of the 
present study and in a few previous reports  [31, 42] . In 
usual conditions, some subjects produce hypo-osmotic 
urine while others show U osm up to 1,200 mosm/kg 
H 2 O. This wide range of spontaneous U osm is possibly 
due to large inter-individual variations in the daily sol-
ute load  [48] , fluid intake  [42] , and thresholds for AVP 
secretion and/or thirst that are, in part, genetically de-
termined  [49] . Both AVP concentration and U osm are 
known to differ between sexes. Men have higher AVP/
copeptin levels  [18, 21, 50] and higher U osm than wom-
en  [31] . This difference is mostly due to the fact that 
men excrete a larger osmolar load than women with a 
higher U osm but an approximatively similar 24-h urine 
volume  [31, 51] . Therefore, in studies using these vari-
ables, data for the 2 sexes are often presented separate-
ly. We verified here the validity of the 2 surrogates in 
each gender. For both genders, the relation between 
eU osm and mU osm is highly significant and the regres-
sion line between these 2 variables is very close to the 
identity line. The UCI also reflected this gender differ-
ence but tended to underestimate it slightly, possibly 
because of the known difference in creatinine handling 
in men and women.
 Differences in the usual urine concentration may be 
associated with the ethnic background. A few studies 
showed that African Americans tend to concentrate urine 
about 20% more than Caucasians and have higher AVP 
levels  [30, 52, 53] . To our knowledge, very few studies 
have evaluated other possible differences in usual urine 
concentration related to habitat or ethnic background 
 [54–58] .
 The results of the SKIPOGH study illustrate the fact 
that urine is usually on the average more concentrat-
ed  during the night than during the day by about 50–
100 mosm/kg H 2 O. Few studies have investigated day and 
night urine separately  [59–61] . They showed that the cir-
cadian pattern of urine flow rate/urine concentration 
and/or sodium excretion rate may be disturbed in some 
subjects. An excessive urine concentration during day-
time, limiting sodium and/or water excretion rate, is sub-
sequently compensated at night by the pressure-natriure-
sis mechanism  [59–63] . Accordingly, measurement of 
U osm in overnight urine samples may not be representa-
tive of 24-h urine.
 There are several advantages for using surrogates of 
U osm . Osmometers, based on either freezing point de-
pression or vapor pressure methods, are expensive and 
rarely equipped with automatic sample changers. Each 
measurement lasts a minute or 2 (due to the time need-
ed to freeze or heat the sample, respectively), thus al-
lowing some evaporation if samples are loaded in the 
changer in advance. We tested the automatic changer 
and observed that mU osm values in the same sample in-
creased after 10 loads. In studies involving a large num-
ber of subjects in which individual measurements are 
practically impossible, values may increase artifactually 
depending on the timing of the measurements. More-
over, osmolality measurements cannot be coupled with 
measurements of various solutes performed by auto-
matic analyzers; they thus require separate aliquots and 
time-consuming manipulations. The excellent correla-
tion between eU osm and mU osm , over the whole range of 
mU osm values, even in CKD, validate eU osm as an ap-
propriate surrogate of mU osm , especially in large co-
horts.
 Urine electrolytes are often available in epidemiologi-
cal studies, but urea, needed for the calculation of eU osm , 
is less frequently measured. When new measurements are 
initiated on previously stored samples in order to evaluate 
the kidney’s concentrating activity, authors should con-
sider the respective advantages of measuring either os-
molality or urea concentration. Urea is much easier, 
quicker, and cheaper to measure than osmolality. More-
over, it will also provide data for a significant solute in the 
urinary concentrating process, and allow an indirect eval-
uation of protein intake.
 This study has some limitations. It concerns exclusive-
ly subjects of European descent. The possible influence of 
sociodemographic factors has not been considered. How-
ever, we think it is reasonable to assume that the highly 
significant correlations between eU osm and mU osm , and 
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the relatively good relationships of UCI with mU osm are 
not dependent upon the population under study and may 
be extended to all populations, as long as the measure-
ments of sodium, potassium, urea, and creatinine con-
centrations are performed in appropriately equipped lab-
oratory with rigorous methods.
 In summary, the present study validates, in large co-
horts, the use of an “estimated osmolarity,” based on the 
measurement of sodium, potassium, and urea, as an ex-
cellent surrogate of the mU osm . It also shows that the 
“urine concentration index,” based on the ratio of creati-
nine concentrations in plasma and urine, may be used as 
a relative index of urine concentration only in subjects 
with normal renal function because of the disturbed han-
dling of creatinine in CKD. In contrast, eU osm is valid 
whatever the level of renal function. In future epidemio-
logic studies addressing the influence of AVP and urinary 
concentrating activity, the use of the “estimated urine os-
molarity” should be recommended when the actual U osm 
cannot be measured.
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